Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
RATIONALE: It is now well established that immune responses can take place outside of primary and secondary lymphoid organs. We previously described the presence of tertiary lymphoid structures (TLS) in patients with non-small cell lung cancer (NSCLC) characterized by clusters of mature dendritic cells (DCs) and T cells surrounded by B-cell follicles. We demonstrated that the density of these mature DCs was associated with favorable clinical outcome. OBJECTIVES: To study the role of follicular B cells in TLS and the potential link with a local humoral immune response in patients with NSCLC. METHODS: The cellular composition of TLS was investigated by immunohistochemistry. Characterization of B-cell subsets was performed by flow cytometry. A retrospective study was conducted in two independent cohorts of patients. Antibody specificity was analyzed by ELISA. MEASUREMENTS AND MAIN RESULTS: Consistent with TLS organization, all stages of B-cell differentiation were detectable in most tumors. Germinal center somatic hypermutation and class switch recombination machineries were activated, associated with the generation of plasma cells. Approximately half of the patients showed antibody reactivity against up to 7 out of the 33 tumor antigens tested. A high density of follicular B cells correlated with long-term survival, both in patients with early-stage NSCLC and with advanced-stage NSCLC treated with chemotherapy. The combination of follicular B cell and mature DC densities allowed the identification of patients with the best clinical outcome. CONCLUSIONS: B-cell density represents a new prognostic biomarker for NSCLC patient survival, and makes the link between TLS and a protective B cell-mediated immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tertiary lymphoid structures (TLS) have recently emerged as biomarkers of response to ICT across several tumor types, including lung cancer, melanoma, RCC, sarcoma, and urothelial cancer (163-167).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [166]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516 · cited 1×
“that a high density of tumor-infiltrating T cells is associated with an increased median survival of cancer patients (9, 10).”
BackgroundSelf-citationThe immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · cited 1×
“The role of T cells especially in the control and eradication of tumors has been largely documented (7, 8).”
BackgroundSelf-citationSpatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Self-citationDangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143 · cited 2×
“Disease-specific survival (DSS) curves were estimated by Kaplan-Meier method and differences between patient groups were calculated using the log-rank test, corrected using the formula proposed by Altman and coworkers (31).”
MethodCD4+ follicular helper T cell infiltration predicts breast cancer survival
Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67428 · Cited by 1,070 · cited 1×
“In that, our strategy parallels the recent work published by GuTrantien and coworkers (43), who showed that tumor infiltration by CXCL13producing CD4(1) follicular helper T cells, one of the major partners of follicular B cells in TLS, is associated with organized immune structures and long-term positive clinical outc…”
ResultDieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031 · cited 5×
“Density of Follicular B Cells Correlates with Long-Term Survival, and a Synergistic Effect Is Observed When Combined with Mature DC Density Because the density of mature DCs was shown to be associated with a favorable prognosis in patients with NSCLC (23), we investigated correlations between follicular B-cell and mat…”
BackgroundMethodInfluentialSelf-citationThe Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
Moyron-Quiroz, J. E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., Woodland, D. L., Lund, F. E., & Randall, T. D. (2004) · Nature Medicine · doi:10.1038/nm1091 · Cited by 821 · cited 1×
“infection, T- and B-cell responses initiated in TLS were protective (26).”
BackgroundLymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776 · cited 1×
“rejection (24), are transient lymphoid structures induced on chronic inflammation in nonlymphoid tissues.”
Background
Cited by
Becht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W. H., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,685
“In lung non-small cell adenocarcinoma, it was recently reported that infiltration by B or T cells independently predicts favorable prognosis [16, 17].”
BackgroundSelf-citationB cells and tertiary lymphoid structures promote immunotherapy response
Helmink, B. A., Reddy, S. M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al. (2020) · Nature · doi:10.1038/s41586-019-1922-8 · Cited by 2,731
“…with existing data regarding a potential prognostic role for TLS in melanoma and other cancer types outside the context of treatment with ICB 18,34,35 , we next assessed the expression of these immune related genes in cutaneous melanoma from The Cancer Genome Atlas platform (TCGA-SKCM, n=136) 36 .”
Self-citationTertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
Self-citationInnate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Lavin, Y., Kobayashi, S., Leader, A., Amir, E.-A. D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C. D., Levine, J. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.014 · Cited by 1,209
Self-citationTertiary lymphoid structures in cancer
Schumacher, T. N., & Thommen, D. S. (2022) · Science · doi:10.1126/science.abf9419 · Cited by 1,142
“Furthermore, evidence that clonal proliferation, isotype switching, and B cell effector differentiation actively take place in TLSs is provided by the detection of activationinduced cytidine deaminase, the enzymedriving somatic hypermutation and class switching, and BCL6, the transcription factor contributing toGC ent…”
Background
Metadata
- Authors
- Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., Validire, P., Damotte, D., Alifano, M., Magdeleinat, P., Cremer, I., Teillaud, J.-L., Fridman, W.-H., Sautès-Fridman, C., & Dieu-Nosjean, M.-C.
- Affiliations
- Université Paris Descartes (FR)
- Memorial Sloan Kettering Cancer Center (US)
- Laboratory “Immune Microenvironment and Tumors” and
- Inserm (FR)
- Clinical Research Unit, Henri Mondor Hospital, Paris, France
- Assistance Publique – Hôpitaux de Paris (FR)
- Institute Mutualiste Montsouris (FR)
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-01
- Volume
- 189
- Issue
- 7
- Pages
- 832-844
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2099900951
- Cited by
- 833
- References
- 51
- Citations by year
- 2026: 55 · 2025: 94 · 2024: 110 · 2023: 108 · 2022: 116 · 2021: 92 · 2020: 59 · 2019: 43 · 2018: 55 · 2017: 25 · 2016: 34 · 2015: 24 · 2014: 15
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- tertiary lymphoid structures, non-small cell lung cancer, follicular B cells, humoral immune response, germinal center, somatic hypermutation, class switch recombination, plasma cells, tumor-associated antibodies, dendritic cells, prognostic factors, survival, tumor microenvironment
- MeSH terms
- Carcinoma, Non-Small-Cell Lung, Dendritic Cells, Enzyme-Linked Immunosorbent Assay, Female, Flow Cytometry, Humans, Immunohistochemistry, Lung Neoplasms, Male, Prognosis, Retrospective Studies, Cohort Studies, Biomarkers, B-Lymphocyte Subsets, Immunity, Humoral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer. https://app.cochat.ai/papers/10.1164/rccm.201309-1611oc
- The paper
- Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., Validire, P., Damotte, D., Alifano, M., Magdeleinat, P., Cremer, I., Teillaud, J.-L., Fridman, W.-H., Sautès-Fridman, C., & Dieu-Nosjean, M.-C. (2014). Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201309-1611oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.